https://www.selleckchem.com/pr....oducts/bms-935177.ht
Baseline characteristics were similar between intervention and control groups. The intervention group, relative to the control group, had significantly improved walking ability at discharge (P  .001). There were no statistically significant differences between the groups in terms of in-hospital adverse events. No adverse effects were detected. In in-hospital patients aged 65 and older, an IAWP improves walking ability at discharge. In in-hospital patients aged 65 and older, an IAWP improves walking ability at discharge. To examin

https://www.selleckchem.com/pr....oducts/gsk2578215a.h
002), and antifungal therapy (7.3% vs 0, p = 0.042) were higher in the corticosteroids group than those in the non-corticosteroids group. Compared to the non-corticosteroids group, more patients developed severe disease (12.7% vs 1.8%, p = 0.028) in the corticosteroids group. There was nosignificantdifference between the two groups in mortality (1.8% vs 0, p = 0.315). In adult patients with non-severe COVID-19 pneumonia, early, low-dose, and short-term corticosteroids therapy was associated with worse clinical outcomes. In adult pat